adenosine 3'-phosphate-5'-phosphate has been researched along with cangrelor in 3 studies
Studies (adenosine 3'-phosphate-5'-phosphate) | Trials (adenosine 3'-phosphate-5'-phosphate) | Recent Studies (post-2010) (adenosine 3'-phosphate-5'-phosphate) | Studies (cangrelor) | Trials (cangrelor) | Recent Studies (post-2010) (cangrelor) |
---|---|---|---|---|---|
102 | 0 | 34 | 418 | 54 | 286 |
Protein | Taxonomy | adenosine 3'-phosphate-5'-phosphate (IC50) | cangrelor (IC50) |
---|---|---|---|
Ornithine decarboxylase | Rattus norvegicus (Norway rat) | 0.0004 | |
P2Y purinoceptor 12 | Homo sapiens (human) | 0.0043 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maayani, S; Martinez, R; Schwarz, T; Tagliente, TM | 1 |
McIntire, LV; Moake, JL; Turner, NA | 1 |
de Groot, PG; IJsseldijk, MJ; Jeninga, EH; Nurden, AT; Nurden, P; Remijn, JA; Sixma, JJ; van Willigen, G; Wu, YP | 1 |
3 other study(ies) available for adenosine 3'-phosphate-5'-phosphate and cangrelor
Article | Year |
---|---|
Activation of Gi-coupled receptors releases a tonic state of inhibited platelet aggregation.
Topics: Adaptation, Physiological; Adenosine Diphosphate; Adenosine Monophosphate; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Clopidogrel; Epinephrine; Female; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; Hirudins; Humans; Male; Membrane Proteins; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Agonists; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-2; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Receptors, Serotonin; Recombinant Proteins; Serotonin; Serotonin Receptor Agonists; Ticlopidine | 2001 |
Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Blood Viscosity; Collagen Type I; Flow Cytometry; Hemorheology; Humans; Image Processing, Computer-Assisted; Membrane Proteins; Microscopy, Fluorescence; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12 | 2001 |
Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aged; Analysis of Variance; Blood Platelets; Humans; Male; Membrane Proteins; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis | 2002 |